scispace - formally typeset
D

Dimphna H. Meijer

Researcher at Harvard University

Publications -  20
Citations -  4879

Dimphna H. Meijer is an academic researcher from Harvard University. The author has contributed to research in topics: OLIG2 & Transcription factor. The author has an hindex of 13, co-authored 17 publications receiving 4254 citations. Previous affiliations of Dimphna H. Meijer include Marine Biological Laboratory & Utrecht University.

Papers
More filters
Journal ArticleDOI

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

TL;DR: Tumour-derived microvesicles may provide diagnostic information and aid in therapeutic decisions for cancer patients through a blood test by incorporating an mRNA for a reporter protein into them, and it is demonstrated that messages delivered by microvesicle are translated by recipient cells.
Journal ArticleDOI

Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2

TL;DR: More recent insights are summarized into the separate roles of these transcription factors in the postnatal brain during repair processes and in neurological disease states, including multiple sclerosis and malignant glioma.
Journal ArticleDOI

Phosphorylation state of Olig2 regulates proliferation of neural progenitors.

TL;DR: It is shown that the proliferative function of Olig2 is controlled by developmentally regulated phosphorylation of a conserved triple serine motif within the amino-terminal domain, which maintains antineural (i.e., promitotic) functions that are reflected in human glioma cells and in a genetically defined murine model of primary gliomas.
Journal ArticleDOI

Directed evolution of adeno-associated virus for glioma cell transduction

TL;DR: A chimeric AAV capsid is obtained that transduces U87 cells at high efficiency (97% at a dose of 104 genome copies/cell), and at low doses it was 1.45–1.6-fold better than AAV2, which proved to be the most efficient parental capsid.
Journal ArticleDOI

Monitoring of Tumor Growth and Post-Irradiation Recurrence in a Diffuse Intrinsic Pontine Glioma Mouse Model

TL;DR: An accurate DIPG mouse model is described that can be of clinical relevance for testing experimental therapeutics in vivo and applied the bioluminescent Fluc signal to monitor tumor recurrence over time.